Nuveen Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.77M | Sell |
171,518
-3,385
| -2% | -$94.2K | ﹤0.01% | 2007 |
|
|
2024
Q3 | $5.02M | Hold |
174,903
| – | – | ﹤0.01% | 1985 |
|
|
2024
Q2 | $4.1M | Buy |
174,903
+30,040
| +21% | +$705K | ﹤0.01% | 2051 |
|
|
2024
Q1 | $3.66M | Buy |
144,863
+12,722
| +10% | +$321K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $3.09M | Buy |
132,141
+658
| +0.5% | +$15.4K | ﹤0.01% | 2211 |
|
|
2023
Q3 | $6.65M | Buy |
131,483
+7,591
| +6% | +$384K | ﹤0.01% | 1719 |
|
|
2023
Q2 | $5.78M | Buy |
123,892
+31,513
| +34% | +$1.47M | ﹤0.01% | 1829 |
|
|
2023
Q1 | $3.53M | Sell |
92,379
-8,139
| -8% | -$311K | ﹤0.01% | 2079 |
|
|
2022
Q4 | $1.23M | Sell |
100,518
-31,727
| -24% | -$389K | ﹤0.01% | 2599 |
|
|
2022
Q3 | $1.62M | Buy |
132,245
+34,800
| +36% | +$427K | ﹤0.01% | 2510 |
|
|
2022
Q2 | $921K | Buy |
97,445
+13,880
| +17% | +$131K | ﹤0.01% | 2821 |
|
|
2022
Q1 | $1.2M | Buy |
83,565
+936
| +1% | +$13.4K | ﹤0.01% | 2742 |
|
|
2021
Q4 | $1.62M | Sell |
82,629
-6,311
| -7% | -$124K | ﹤0.01% | 2666 |
|
|
2021
Q3 | $2.21M | Sell |
88,940
-5,384
| -6% | -$134K | ﹤0.01% | 2622 |
|
|
2021
Q2 | $2.34M | Buy |
94,324
+43,958
| +87% | +$1.09M | ﹤0.01% | 2632 |
|
|
2021
Q1 | $1.46M | Sell |
50,366
-939
| -2% | -$27.2K | ﹤0.01% | 2756 |
|
|
2020
Q4 | $1.32M | Sell |
51,305
-17,519
| -25% | -$452K | ﹤0.01% | 2696 |
|
|
2020
Q3 | $2.12M | Buy |
68,824
+24,133
| +54% | +$743K | ﹤0.01% | 2354 |
|
|
2020
Q2 | $1.11M | Buy |
44,691
+26,915
| +151% | +$671K | ﹤0.01% | 2580 |
|
|
2020
Q1 | $377K | Buy |
+17,776
| New | +$377K | ﹤0.01% | 2863 |
|